Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

November 8, 2017

Study Completion Date

November 28, 2017

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

BCT197

Capsules will be taken orally with fluids over a 5 day period after randomization

DRUG

Placebo

Capsules will be taken orally with fluids over a 5 day period after randomization

Trial Locations (46)

Unknown

Mereo Research Site, Michigan City

Mereo Research Site, Baltimore

Mereo Research Site, Milwaukee

Mereo Research Site, Dupnitsa

Mereo Research Site, Gabrovo

Mereo Research Site, Kardzhali

Mereo Research Site, Kozloduy

Mereo Research Site, Kyustendil

Mereo Research Site, Lovech

Mereo Research Site, Montana

Mereo Research Site, Razgrad

Mereo Research Site, Rousse

Mereo Research Site, Shumen

Mereo Research Site, Sliven

Mereo Research Site, Sofia

Mereo Research Site, Kyjov

Mereo Research Site, Mělník

Mereo Research Site, Slaný

Mereo Research Site, Dresden

Mereo Research Site, Balassagyarmat

Mereo Research Site, Budapest

Mereo Research Site, Debrecen

Mereo Research Site, Farkasgyepű

Mereo Research Site, Miskolc

Mereo Research Site, Mohács

Mereo Research Site, Naples

Mereo Research Site, Daugavpils

Mereo Research Site, Riga

Mereo Research Site, Valmiera

Mereo Research Site, Chrzanów

Mereo Research Site, Krakow

Mereo Research Site, Proszowice

Mereo Research Site, Wroclaw

Mereo Research Site, Zgierz

Mereo Research Site, Bucharest

Mereo Research Site, Cluj-Napoca

Mereo Research Site, Constanța

Mereo Research Site, Craiova

Mereo Research Site, Marghita

Mereo Research Site, Suceava

Mereo Research Site, Timișoara

Mereo Research Site, Izhevsk

Mereo Research Site, Kemerovo

Mereo Research Site, Saint Petersburg

Mereo Research Site, Saratov

Mereo Research Site, Tomsk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mereo BioPharma

INDUSTRY

NCT02700919 - Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter